相关实验视频

Updated: Jan 13, 2026

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

Published on: January 21, 2018

波扬:对法里西马布进行的第三阶段随机临床试验,用于治疗病理近视后的胸腔新血管化:研究设计和理由

Timothy Y Y Lai¹, Luis Arias², Chui Ming Gemmy Cheung³

¹Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

|October 29, 2025

概括

在POYANG研究中,评估法里西马布与拉尼比祖马布对病态近视相关的胆道新血管化 (mCNV). 这一第三阶段试验评估了法里西马布的价值.

科学领域:

眼科医生眼科眼科
医学研究医学研究
临床试验临床试验

背景情况:

病态近视可以导致胆道新血管化 (mCNV),这是视力丧失的重要原因.
目前对mCNV的治疗有局限性,需要对新型治疗剂进行研究.
费里西马布是血管内皮素-2和血管内皮细胞生长因子A的双重抑制剂,为潜在的新疗法提供了选择.

研究的目的:

描述POYANG研究的设计,一个国际第三阶段试验.
评估法里西马布与拉尼比祖马布在mCNV患者中的疗效和安全性.
评估法里西马布作为治疗mCNV.mCNV的双重抑制剂.

主要方法:

国际,随机,双面罩,多中心,主动对比者控制的第三期试验.
没有接受过治疗的mCNV的成年患者被随机分类1:1给法里西马布6.0毫克或拉尼比祖马布0.5毫克.
在为期48周的研究期内,按视敏度和视网膜厚度为基础的每月检查和再治疗标准进行了预产后 (PRN) 剂量方案.

主要成果:

从11个国家招募约280名mCNV患者.
主要终点:法里西马布与拉尼比祖马布在4,8和12周最佳校正视敏度 (BCVA) 变化中的非劣势.
二级终点包括中心子场厚度 (CST) 和治疗频率的变化;不良事件将受到监测.

结论:

波扬试验是第三阶段注册研究.
它研究了法里西马布在mCNV患者中的疗效和安全性.
这项研究旨在提供关于法里西马布治疗mCNV的关键数据.

关键词:

(35): 病态近视; 冠状腺新血管化.格-2 的意思是说,格-2 的意思是说.抗-VEGFF的方法是什么

更多相关视频

Inducement and Evaluation of a Murine Model of Experimental Myopia

Inducement and Evaluation of a Murine Model of Experimental Myopia

Published on: January 22, 2019

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...